Cooperman Leon G Takes Position in Amrize Ltd $AMRZ

Cooperman Leon G bought a new stake in Amrize Ltd (NYSE:AMRZFree Report) in the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm bought 880,000 shares of the company’s stock, valued at approximately $42,706,000. Amrize makes up about 1.3% of Cooperman Leon G’s investment portfolio, making the stock its 22nd biggest holding. Cooperman Leon G owned 0.16% of Amrize at the end of the most recent quarter.

Other large investors also recently bought and sold shares of the company. State of Wyoming bought a new position in Amrize during the third quarter valued at $32,000. US Bancorp DE purchased a new position in shares of Amrize in the 3rd quarter worth $38,000. Costello Asset Management INC bought a new stake in shares of Amrize in the 3rd quarter worth about $44,000. Global Retirement Partners LLC bought a new stake in shares of Amrize in the 3rd quarter worth about $48,000. Finally, Jones Financial Companies Lllp purchased a new stake in shares of Amrize during the 3rd quarter valued at about $53,000.

Amrize Price Performance

Shares of AMRZ stock opened at $55.51 on Friday. The company has a market capitalization of $30.70 billion and a P/E ratio of 22.56. The company’s 50-day simple moving average is $57.93 and its two-hundred day simple moving average is $53.68. Amrize Ltd has a one year low of $44.12 and a one year high of $65.94. The company has a debt-to-equity ratio of 0.37, a current ratio of 1.64 and a quick ratio of 1.10.

Amrize (NYSE:AMRZGet Free Report) last posted its quarterly earnings results on Tuesday, February 17th. The company reported $0.62 earnings per share for the quarter, beating the consensus estimate of $0.59 by $0.03. The company had revenue of $2.84 billion for the quarter, compared to the consensus estimate of $2.95 billion. The firm’s revenue was down .4% compared to the same quarter last year.

Insider Transactions at Amrize

In other news, CTO Roald Brouwer bought 3,000 shares of the firm’s stock in a transaction on Wednesday, March 11th. The stock was acquired at an average cost of $58.72 per share, with a total value of $176,160.00. Following the transaction, the chief technology officer directly owned 16,257 shares in the company, valued at approximately $954,611.04. This trade represents a 22.63% increase in their position. The acquisition was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, insider Jaime Hill bought 3,184 shares of the stock in a transaction on Monday, March 9th. The stock was purchased at an average price of $56.34 per share, with a total value of $179,386.56. Following the completion of the acquisition, the insider directly owned 26,000 shares in the company, valued at approximately $1,464,840. This trade represents a 13.96% increase in their position. The disclosure for this purchase is available in the SEC filing. Over the last 90 days, insiders have purchased 72,634 shares of company stock valued at $4,224,656.

Analysts Set New Price Targets

AMRZ has been the subject of a number of analyst reports. UBS Group increased their price target on shares of Amrize from $53.00 to $57.00 and gave the company a “neutral” rating in a report on Thursday, January 8th. JPMorgan Chase & Co. boosted their price objective on Amrize from $60.00 to $70.00 and gave the stock an “overweight” rating in a research note on Thursday, March 5th. Citigroup upped their price objective on Amrize from $63.00 to $67.00 and gave the company a “buy” rating in a research report on Thursday, January 8th. Deutsche Bank Aktiengesellschaft reaffirmed a “buy” rating on shares of Amrize in a research note on Monday, February 23rd. Finally, Wells Fargo & Company lifted their target price on Amrize from $59.00 to $66.00 and gave the stock an “overweight” rating in a report on Thursday, February 19th. One analyst has rated the stock with a Strong Buy rating, nine have issued a Buy rating and seven have given a Hold rating to the company’s stock. According to MarketBeat.com, Amrize currently has an average rating of “Moderate Buy” and an average price target of $64.14.

Check Out Our Latest Stock Analysis on Amrize

Amrize Company Profile

(Free Report)

Amrize AG focuses on building materials business in North America. The company was incorporated in 2023 and is based in Zug, Switzerland. Amrize AG operates independently of Holcim AG as of June 23, 2025.

Recommended Stories

Institutional Ownership by Quarter for Amrize (NYSE:AMRZ)

Receive News & Ratings for Amrize Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amrize and related companies with MarketBeat.com's FREE daily email newsletter.